Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: Poland Clear all

212 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20021
20035
20047
20058
200614
20073
200817
200914
201020
20117
201214
201310
20148
20157
20167
201714
20187
20197
20204
20216
20223
20235
20247
20253
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed172
Terminated20
Recruiting11
Active, not recruiting5
Withdrawn2
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S51
AstraZeneca32
Eli Lilly and Company23
Sanofi19
Takeda18
Boehringer Ingelheim9
Janssen Research & Development, LLC9
Hoffmann-La Roche8
Lexicon Pharmaceuticals5
Mannkind Corporation4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2212
Diabetes Mellitus61
Glucose Metabolism Disorders15
Obesity13
Dyslipidemias10
Overweight9
Renal Insufficiency, Chronic9
Cardiovascular Diseases8
Metabolic Diseases7
Endocrine System Diseases6

Trials

Showing 1 to 25 of 212. Each trial links to its page on Pharma Observatory.

112 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.